D Collen

763 total citations
22 papers, 616 citations indexed

About

D Collen is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, D Collen has authored 22 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Hematology. Recurrent topics in D Collen's work include Protease and Inhibitor Mechanisms (13 papers), Blood properties and coagulation (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). D Collen is often cited by papers focused on Protease and Inhibitor Mechanisms (13 papers), Blood properties and coagulation (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). D Collen collaborates with scholars based in Belgium, United States and France. D Collen's co-authors include H.R. Lijnen, H.R. Lijnen, F De Cock, Frans Van de Werf, H Bounameaux, M Verstraete, José A. Páramo, Mario Colucci, DC Stump and Veerle Darras and has published in prestigious journals such as Circulation, Journal of Pharmacology and Experimental Therapeutics and Thrombosis and Haemostasis.

In The Last Decade

D Collen

22 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Collen Belgium 11 299 293 185 115 101 22 616
Dmitry V. Sakharov Netherlands 7 252 0.8× 140 0.5× 202 1.1× 81 0.7× 87 0.9× 9 553
K. Bykowska Poland 13 240 0.8× 71 0.2× 122 0.7× 71 0.6× 107 1.1× 44 486
H Moreau Belgium 11 101 0.3× 126 0.4× 64 0.3× 56 0.5× 121 1.2× 18 527
Binder Br Austria 10 111 0.4× 201 0.7× 80 0.4× 29 0.3× 126 1.2× 16 398
JR Maynard United States 6 317 1.1× 61 0.2× 78 0.4× 59 0.5× 99 1.0× 7 504
J.J. Ryckewaert France 8 292 1.0× 73 0.2× 162 0.9× 53 0.5× 126 1.2× 9 559
M. Bérard France 15 225 0.8× 53 0.2× 24 0.1× 77 0.7× 105 1.0× 34 586
M C Boffa France 12 262 0.9× 41 0.1× 51 0.3× 76 0.7× 84 0.8× 25 521
Richard A. Logan United Kingdom 7 39 0.1× 146 0.5× 78 0.4× 102 0.9× 82 0.8× 10 470
Jian-Ming Gu United States 14 767 2.6× 34 0.1× 37 0.2× 120 1.0× 143 1.4× 21 978

Countries citing papers authored by D Collen

Since Specialization
Citations

This map shows the geographic impact of D Collen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Collen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Collen more than expected).

Fields of papers citing papers by D Collen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Collen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Collen. The network helps show where D Collen may publish in the future.

Co-authorship network of co-authors of D Collen

This figure shows the co-authorship network connecting the top 25 collaborators of D Collen. A scholar is included among the top collaborators of D Collen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Collen. D Collen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jespers, Laurent, Sophie Vanwetswinkel, H.R. Lijnen, et al.. (1999). Structural and Functional Basis of Plasminogen Activation by Staphylokinase. Thrombosis and Haemostasis. 81(4). 479–485. 26 indexed citations
2.
Zoldhelyi, Pierre, et al.. (1995). Effects of Heparin and Hirudin (CGP 39393) on Thrombin Generation During Thrombolysis for Acute Myocardial Infarction. Circulation. 92(8). 3555–3555. 6 indexed citations
3.
Liao, Jun, Jef Arnout, Philippe Vanhove, et al.. (1995). Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.. PubMed. 6(3). 257–63. 10 indexed citations
4.
Leonardsson, Göran, et al.. (1994). Regulation of the fibrinolytic system during gonadotropin-induced ovulation in mice with inactivation of the genes encoding tPA, uPA or PAI-i. Fibrinolysis and Proteolysis. 8. 101–101. 2 indexed citations
5.
Lijnen, H.R. & D Collen. (1988). Mechanisms of Plasminogen Activation by MammalianPlasminogen Activators. Enzyme. 40(2-3). 90–96. 20 indexed citations
7.
Declerck, Paul, Peter Mombaerts, Paul Holvoet, & D Collen. (1987). PLASMA LEVELS OF FRAGMENT D-DIMER OF CROSSLINKED FIBRIN DURING THROMBOLYTIC THERAPY WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR. Thrombosis and Haemostasis. 10 indexed citations
8.
Cambier, Patrick, Frans Van de Werf, & D Collen. (1987). CORONARY THROMBOLYSIS IN DOGS WITH A NONGLYCOSYLATED VARIANT OF HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR LACKING THE FINGER AND GROWTH FACTOR DOMAINS. Thrombosis and Haemostasis. 6 indexed citations
9.
Collen, D, F De Cock, E Demarsin, H.R. Lijnen, & D C Stump. (1986). Absence of Synergism Between Tissue-Type Plasminogen Activator (t-PA), Single-Chain UrokinaseType Plasminogen Activator (scu-PA) and Urokinase on Clot Lysis in a Plasma Milieu In Vitro. Thrombosis and Haemostasis. 56(1). 35–39. 42 indexed citations
10.
Collen, D & H Bounameaux. (1986). Coronary thrombolysis with clot-selective plasminogen activators.. PubMed. 11(1). 9–15. 4 indexed citations
11.
Colucci, Mario, José A. Páramo, & D Collen. (1986). Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.. PubMed. 108(1). 53–9. 53 indexed citations
12.
13.
Collen, D & H.R. Lijnen. (1986). Tissue-Type Plasminogen Activator. Pathophysiology of Haemostasis and Thrombosis. 16(Suppl. 3). 25–32. 67 indexed citations
14.
Verstraete, M, H Bounameaux, F De Cock, Frans Van de Werf, & D Collen. (1985). Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans.. Journal of Pharmacology and Experimental Therapeutics. 235(2). 506–512. 129 indexed citations
15.
Collen, D. (1985). Report of the Meeting of the Subcommittee on Fibrinolysis, San Diego, CA, USA, July 13, 1985. Thrombosis and Haemostasis. 54(4). 893–893. 27 indexed citations
16.
Collen, D, et al.. (1982). In vivo studies of a synthetic inhibitor of thrombin.. PubMed. 99(1). 76–83. 41 indexed citations
17.
Rijken, D C, Marc Hoylaerts, & D Collen. (1981). On The Fibrinolytic Properties Of Single-Chain And Two- Chain Human Tissue Plasminogen Activator. Thrombosis and Haemostasis. 1 indexed citations
18.
Hoylaerts, Marc, et al.. (1981). Kinetics Of Plasminogen Activation By Tissue Plasminogen Activator. Role Of Fibrin. Thrombosis and Haemostasis. 46. 6 indexed citations
19.
Tytgat, G. N. J., et al.. (1972). Fibrinogen Metabolism in Healthy Dogs and in Dogs with CCI4-Induced Liver Damage and with Portal Vein Occlusion. Thrombosis and Haemostasis. 27(2). 319–336. 2 indexed citations
20.
Gn, Tytgat, D Collen, & M Verstraete. (1971). Metabolism of fibrinogen in cirrhosis of the liver.. PubMed. 64(10). 1690–701. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026